Available IPD datapackage for study 'A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus'
收藏DataCite Commons2025-08-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00008208.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment
regimen of two doses of anifrolumab versus placebo in adult subjects with moderately to
severely active, autoantibody-positive systemic lupus erythematosus (SLE).
提供机构：
Vivli
创建时间：
2025-08-27
